A summary of the current drug interaction guidance from the European Medicines Agency and considerations of future updates-Reference-Cited by-同舟云学术

A summary of the current drug interaction guidance from the European Medicines Agency and considerations of future updates

Published:2020-02 Issue:1 Volume:35 Page:2-11
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Cole Susan,Kerwash Essam,Andersson Anita

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference17 articles.

1. Committee for human medicinal products (CHMP) of the European Medicines agency (EMA). Doc. Ref. CPMP/EWP/560/95/Rev. 1 corr. 2**;Guideline on the Investigation of Drug Interactions,2012

2. Committee for human medicinal products (CHMP) of the European Medicines agency (EMA). Doc. Ref. EMEA/CHMP/694687/2016;Concept paper on a revision of the Guideline on the 4 investigation of drug interactions,2017

3. Committee for human medicinal products (CHMP) of the European Medicines agency (EMA). Doc. Ref. EMA/CHMP/458101/2016;Guideline on the reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations;Drug Metabolism Reviews;2024-05-03

2. Survey of Pharmaceutical Industry’s Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group;Drug Metabolism and Disposition;2024-05-02

3. Xenografted Tumors Share Comparable Fraction Unbound and Can Be Surrogated by Mouse Lung Tissue;Drug Metabolism and Disposition;2024-04-26

4. Drug Transporters;ADME Processes in Pharmaceutical Sciences;2024

5. Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model-informed precision dosing;Frontiers in Pharmacology;2023-07-20